Create a free QxMD account to take advantage of the features offered by Read like saving your papers and creating collections.

Get Started

LETTER

Chloroquine and hydroxychloroquine to treat COVID-19: between hope and caution

Bruno Mégarbane

Clinical Toxicology 2020 April 2, : 1-2

No abstract text is available yet for this article.

Full Text Links

We have located open access full text paper links.

Full Text PDF

Additional links

PubMed

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Aminoquinolines Against Coronavirus Disease 2019 (COVID-19): Chloroquine or Hydroxychloroquine. Zahra Sahraei, Minoosh Shabani, Shervin Shokouhi, Ali Saffaei International Journal of Antimicrobial Agents 2020 March 16, : 105945

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Philippe Gautret, Jean-Christophe Lagier, Philippe Parola, Van Thuan Hoang, Line Meddeb, Morgane Mailhe, Barbara Doudier, Johan Courjon, Valérie Giordanengo, Vera Esteves Vieira, Hervé Tissot Dupont, Stéphane Honoré, Philippe Colson, Eric Chabrière, Bernard La Scola, Jean-Marc Rolain, Philippe Brouqui, Didier Raoult International Journal of Antimicrobial Agents 2020 March 20, : 105949

Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use. Sairam Atluri, Laxmaiah Manchikanti, Joshua A Hirsch Pain Physician 2020, 23 (2): E71-E83

Cross-Reactivity of Chloroquine and Hydroxychloroquine With DRI Amphetamine Immunoassay. Isabel Gomila, Loreto Quesada, Victoria López-Corominas, Julia Fernández, Miguel Á Servera, Laura Sahuquillo, Macarena Dastis, Albert Torrents, Bernardino Barceló Therapeutic Drug Monitoring 2017, 39 (2): 192-196

Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review. Domenico Plantone, Tatiana Koudriavtseva Clinical Drug Investigation 2018, 38 (8): 653-671

A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. Andrea Cortegiani, Giulia Ingoglia, Mariachiara Ippolito, Antonino Giarratano, Sharon Einav Journal of Critical Care 2020 March 10

Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know. Jinoos Yazdany, Alfred H J Kim Annals of Internal Medicine 2020 June 2, 172 (11): 754-755

Could Chloroquine /Hydroxychloroquine Be Harmful in Coronavirus Disease 2019 (COVID-19) Treatment? Maurizio Guastalegname, Alfredo Vallone Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2020 July 28, 71 (15): 888-889

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Philippe Colson, Jean-Marc Rolain, Jean-Christophe Lagier, Philippe Brouqui, Didier Raoult International Journal of Antimicrobial Agents 2020 March 4, : 105932

Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Jianjun Gao, Zhenxue Tian, Xu Yang Bioscience Trends 2020 March 16, 14 (1): 72-73

Make the most of Read.
Download the mobile app.

Want full text access to this paper?

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

Chloroquine and hydroxychloroquine to treat COVID-19: between hope and caution

Discussion

Related Papers

Want full text access to this paper?

Save your favorite articles in one place with a free QxMD account.

Read

Search Tips